Graves' ophthalmopathy: interdisciplinary approach

Graves' ophthalmopathy constitutes a major therapeutic challenge, so specialists of various disci-plines have to combine their forces. According to the last consensus of EUGOGO (European Group On Graves' Orbitopathy) the treatment of choice for Graves' ophthalmopathy is pulses of gluc...

Full description

Bibliographic Details
Format: Article
Language:Russian
Published: Endocrinology Research Centre 2010-12-01
Series:Клиническая и экспериментальная тиреоидология
Subjects:
Online Access:https://cet-endojournals.ru/ket/article/viewFile/4344/2471
id doaj-419917c8ccb04864bf3eaaac3b8a9440
record_format Article
spelling doaj-419917c8ccb04864bf3eaaac3b8a94402021-06-02T19:40:46ZrusEndocrinology Research CentreКлиническая и экспериментальная тиреоидология1995-54722310-37872010-12-0164465110.14341/ket20106446-514302Graves' ophthalmopathy: interdisciplinary approachGraves' ophthalmopathy constitutes a major therapeutic challenge, so specialists of various disci-plines have to combine their forces. According to the last consensus of EUGOGO (European Group On Graves' Orbitopathy) the treatment of choice for Graves' ophthalmopathy is pulses of glucocorticoid (GC). Evidence for the superiority of any of the different intravenous (iv) glucocorticoid schedules is lacking. Objective: to evaluate the efficacy of two different methylprednisolone pulse therapy schedules in Graves' ophthalmopathy. Materials and Methods: 30 Graves' patients with Graves' ophthalmopathy were subcategorized into two groups: Group A subjects (n = 14) were given iv glucocorticoid daily for 5 days (total 5 g) and Group B patients (n = 16) were given iv glucocorticoid weekly for 5 weeks (total 5 g). All patients were examined by the ophthalmologist before and in 1 and 12 weeks after the treatment. Results: We found that in group A visual acuity was significantly higher than in group B at 12 weeks. By 12 week proptosis, diplopia had improved as well as CAS had fallen in two groups but there were no significant differences between the two groups. Conclusion: Both schedules are effective on proptosis, soft tissue swelling. Daily pulse therapy appeared to be more effective on visual acuity. Thereby in case of active Graves' ophthalmopathy associated with impairment of visual acuity, daily pulse therapy is a treatment of choice. But, in spite of improvement, strabismus, diplopia, proptosis have a marked negative effect on quality of life, disturb a lifestyle. In these cases surgery should be considered. After end of our research two patients (3 orbits) had bone decompression with a good result. We consider that eye muscle surgery is next needed to restore their binocular vision.https://cet-endojournals.ru/ket/article/viewFile/4344/2471graves' ophthalmopathygraves' diseasesteroid pulse therapyorbital decompression
collection DOAJ
language Russian
format Article
sources DOAJ
title Graves' ophthalmopathy: interdisciplinary approach
spellingShingle Graves' ophthalmopathy: interdisciplinary approach
Клиническая и экспериментальная тиреоидология
graves' ophthalmopathy
graves' disease
steroid pulse therapy
orbital decompression
title_short Graves' ophthalmopathy: interdisciplinary approach
title_full Graves' ophthalmopathy: interdisciplinary approach
title_fullStr Graves' ophthalmopathy: interdisciplinary approach
title_full_unstemmed Graves' ophthalmopathy: interdisciplinary approach
title_sort graves' ophthalmopathy: interdisciplinary approach
publisher Endocrinology Research Centre
series Клиническая и экспериментальная тиреоидология
issn 1995-5472
2310-3787
publishDate 2010-12-01
description Graves' ophthalmopathy constitutes a major therapeutic challenge, so specialists of various disci-plines have to combine their forces. According to the last consensus of EUGOGO (European Group On Graves' Orbitopathy) the treatment of choice for Graves' ophthalmopathy is pulses of glucocorticoid (GC). Evidence for the superiority of any of the different intravenous (iv) glucocorticoid schedules is lacking. Objective: to evaluate the efficacy of two different methylprednisolone pulse therapy schedules in Graves' ophthalmopathy. Materials and Methods: 30 Graves' patients with Graves' ophthalmopathy were subcategorized into two groups: Group A subjects (n = 14) were given iv glucocorticoid daily for 5 days (total 5 g) and Group B patients (n = 16) were given iv glucocorticoid weekly for 5 weeks (total 5 g). All patients were examined by the ophthalmologist before and in 1 and 12 weeks after the treatment. Results: We found that in group A visual acuity was significantly higher than in group B at 12 weeks. By 12 week proptosis, diplopia had improved as well as CAS had fallen in two groups but there were no significant differences between the two groups. Conclusion: Both schedules are effective on proptosis, soft tissue swelling. Daily pulse therapy appeared to be more effective on visual acuity. Thereby in case of active Graves' ophthalmopathy associated with impairment of visual acuity, daily pulse therapy is a treatment of choice. But, in spite of improvement, strabismus, diplopia, proptosis have a marked negative effect on quality of life, disturb a lifestyle. In these cases surgery should be considered. After end of our research two patients (3 orbits) had bone decompression with a good result. We consider that eye muscle surgery is next needed to restore their binocular vision.
topic graves' ophthalmopathy
graves' disease
steroid pulse therapy
orbital decompression
url https://cet-endojournals.ru/ket/article/viewFile/4344/2471
_version_ 1721401475937075200